Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus

Simple item page
dc.article.end-page1625en
dc.article.start-page1616en
dc.citation.doi10.1093/INFDIS/JIAC174en
dc.contributor.authorZ Cindien
dc.contributor.authorA Kawumaen
dc.contributor.authorG Maartensen
dc.contributor.authorY Bradforden
dc.contributor.authorWillem Venteren
dc.contributor.authorSimiso Sokhelaen
dc.contributor.authorNomathemba Chandiwanaen
dc.contributor.authorE et alen
dc.date.accessioned2024-07-23T05:54:12Z
dc.date.available2024-07-23T05:54:12Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0022-1899en
dc.identifier.urihttps://hdl.handle.net/10539/39028
dc.journal.titlePharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virusen
dc.journal.volume226en
dc.publisherOXFORD UNIV PRESS INCen
dc.titlePharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virusen
dc.typeJournal Articleen
Files
Collections
Academic Wits Research Outputs (All submissions)